Your Guide to FDA-Approved Alzheimer’s Drugs
Alzheimer’s disease affects one in every three people over the age of 85, and the scale of the epidemic is only worsening. While there…
Alzheimer’s disease affects one in every three people over the age of 85, and the scale of the epidemic is only worsening. While there…
A new generation of Alzheimer’s treatments — groundbreaking, disease-modifying monoclonal antibody drugs — is on the rise, and two so far have hit the…
Clinical trials and studies scientific experiments that investigate new treatments, lifestyle interventions, or risk factors for developing a disease like Alzheimer’s or dementia. By…
In January of 2023, the Food and Drug Administration approved the second anti-amyloid therapy for Alzheimer’s disease, Leqembi (generic name lecanemab). A new Alzheimer’s…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Some of the United States’s most widespread…
I’m writing from Amsterdam, where this past week, the Being Patient editorial team has been reporting on the biggest news from the Alzheimer’s Association…
AMSTERDAM —In the data presented at this week’s Alzheimer’s Association International Conference in Amsterdam, donanemab has been shown to slow development of memory and…
As I prepared to board the plane to Amsterdam for the Alzheimer’s Association International Conference, an email from the news site Axios caught my…
AMSTERDAM — When we arrived at the Rijks Museum, the home of Netherland’s most cherished artwork and cultural heritage, the halls were pretty empty…
A record number of people — 6,524 and counting — are expected in Amsterdam next week for the annual Alzheimer’s Association International Conference. As…
We arrived at the emergency vet at 1 a.m. Our 10-month-old kitten, Pippin, had started breathing oddly earlier in the day but we thought…
American pharmaceutical company Eli Lilly announced in May 2023 that it had seen encouraging clinical trial results of its new Alzheimer’s medication. According to…
Scientists still aren’t sure what causes Alzheimer’s, but they have figured out that the progression of this disease is closely linked to the buildup…
More than six million Americans currently live with Alzheimer’s. By 2050, more than 13 million Americans may develop the condition. But despite decades of…
After almost two decades of stagnation, two new drugs for Alzheimer’s have hit the market in the last three years. The approval of Biogen…